Donaldson reports record Q3 FY2026 sales of $995.1M, raises full-year guidance
Donaldson Company delivered record third quarter sales and adjusted operating margins while closing the margin-accretive Facet acquisition. The company narrowed fiscal 2026 guidance upward, citing strong Mobile and Life Sciences segment performance and robust order backlogs.
View filing at SEC.gov →